Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins

Annual Review of Cell and Developmental Biology

Volumn 14, Issue , 1998, Pages 167-196

  Black, Brian L ^a,b   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiac development; Gene expression; MADS box; Myogenesis; Transcription factor

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; CELL PROLIFERATION; ENHANCER REGION; GENE INDUCTION; GENE TARGETING; HEART DEVELOPMENT; METAZOON; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

ANIMALS; DNA-BINDING PROTEINS; GROWTH SUBSTANCES; HEART; HUMANS; MORPHOGENESIS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCLE, SMOOTH; MYOGENIC REGULATORY FACTORS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA; METAZOA;

EID: 0032437107     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.14.1.167     Document Type: Review

References (141)

1. Acton TB, Zhong H, Vershon AK. 1997. DNA-binding specificity of Mcm1: operator mutations that alter DNA-bending and transcriptional activities by a MADS box protein. Mol. Cell. Biol. 17:1881-89
2. Adolph EA, Subramaniam A, Cserjesi P, Olson EN, Robbins J. 1993. Role of myocyte-specific enhancer-binding factor (MEF-2) in transcriptional regulation of the alpha-cardiac myosin heavy chain gene. J. Biol. Chem. 268:5349-52
3. Amacher SL, Buskin JN, Hauschka SD. 1993. Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle. Mol. Cell. Biol. 13:2753-64
4. Andres V, Cervera M, Mahdavi V. 1995a. Determination of the consensus binding site for MEF2 expressed in muscle and brain reveals tissue-specific sequence constraints. J. Biol. Chem. 270:23246-49
5. Andres V, Fisher S, Wearsch P, Walsh K. 1995b. Regulation of Gax homeobox gene transcription by a combination of positive factors including myocyte-specific enhancer factor 2. Mol. Cell. Biol. 15:4272-81
6. Azpiazu N, Frasch M. 1993. tinman and bagpipe: two homeo box genes that determine cell fates in the dorsal mesoderm of Drosophila. Genes Dev. 7:1325-40
7. Bassel-Duby R, Hernandez MD, Gonzalez MA, Krueger JK, Williams RS. 1992. A 40-kilodalton protein binds specifically to an upstream sequence element essential for muscle-specific transcription of the human myoglobin promoter. Mol. Cell. Biol. 12:5024-32
8. Baylies MK, Bate M. 1996. twist: a myogenic switch in Drosophila. Science 272:1481-84
9. Black BL, Ligon KL, Zhang Y, Olson EN. 1996. Cooperative transcriptional activation by the neurogenic basic helix-loop-helix protein MASH1 and members of the myocyte enhancer factor-2 (MEF2) family. J. Biol. Chem. 271:26659-63
10. Black BL, Lu J, Olson EN. 1997. The MEF2A 3′ untranslated region functions as a cis-acting translational repressor. Mol. Cell. Biol. 17:2756-63
11. Black BL, Martin JF, Olson EN. 1995. The mouse MRF4 promoter is trans-activated directly and indirectly by muscle-specific transcription factors. J. Biol. Chem. 270:2889-92
12. Black BL, Molkentin JD, Olson EN. 1998. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. Mol. Cell. Biol. 18:69-77
13. Bodmer R. 1993. The gene tinman is required for specification of the heart and visceral muscles in Drosophila [published erratum appears in Development 119(3):969], Development 118:719-29
14. Bour BA, O'Brien MA, Lockwood WL, Goldstein ES, Bodmer R, et al. 1995. Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev. 9:730-41
15. Breitbart RE, Liang CS, Smoot LB, Laheru DA, Mahdavi V, Nadal-Ginard B. 1993. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development 118:1095-106
16. Brennan TJ, Chakraborty T, Olson EN. 1991. Mutagenesis of the myogenin basic region identifies an ancient protein motif critical for activation of myogenesis. Proc. Natl. Acad. Sci. USA 88:5675-79
17. Buchberger A, Ragge K, Arnold HH. 1994. The myogenin gene is activated during myocyte differentiation by pre-existing, not newly synthesized transcription factor MEF-2. J. Biol. Chem. 269:17289-96
18. Chambers AE, Kotecha S, Towers N, Mohun TJ. 1992. Muscle-specific expression of SRF-related genes in the early embryo of Xenopus laevis. EMBO J. 11:4981-91
19. Chambers AE, Logan M, Kotecha S, Towers N, Sparrow D, Mohun TJ. 1994. The RSRF/MEF2 protein SL1 regulates cardiac muscle-specific transcription of a myosin light-chain gene in Xenopus embryos. Genes Dev. 8:1324-34
20. Cheng TC, Wallace MC, Merlie JP, Olson EN. 1993. Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science 261:215-18
21. Coso OA, Montaner S, Fromm C, Lacal JC, Prywes R, et al. 1997. Signaling from G protein-coupled receptors to the c-jun promoter involves the MEF2 transcription factor. Evidence for a novel c-jun amino-terminal kinase-independent pathway. J. Biol. Chem. 272:20691-97
22. Cripps RM, Black BL, Zhao B, Lien CL, Schulz RA, Olson EN. 1998. The myogenic regulatory gene Mef2 is a direct target for transcriptional activation by Twist during Drosophila myogenesis. Genes Dev. 12:422-34
23. Cserjesi P, Lilly B, Hinkley C, Perry M, Olson EN. 1994. Homeodomain protein MHox and MADS protein myocyte enhancer-binding factor-2 converge on a common element in the muscle creatine kinase enhancer. J. Biol. Chem. 269:16740-5
24. Cserjesi P, Olson EN. 1991. Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol. Cell. Biol. 11:4854-62
25. Davis RL, Cheng PF, Lassar AB, Weintraub H. 1990. The MyoD binding domain contains a recognition code for muscle-specific gene activation. Cell 60:733-46
26. Davis RL, Weintraub H. 1992. Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12. Science 256:1027-30
27. Dechesne CA, Wei Q, Eldridge J, Gannoun-Zaki L, Millasseau P, et al. 1994. E-box-and MEF-2-independent muscle-specific expression, positive autoregulation, and cross-activation of the chicken MyoD (CMD1) promoter reveal an indirect regulatory pathway. Mol. Cell. Biol. 14:5474-86
28. Dodou E, Sparrow DB, Mohun T, Treisman R. 1995. MEF2 proteins, including MEF2A, are expressed in both muscle and non-muscle cells. Nucleic Acids Res. 23:4267-74
29. Dodou E, Treisman R. 1997. The Saccharomyces cerevisiae MADS-box transcription factor R1m1 is a target for the Mpk1 mitogen-activated protein kinase pathway. Mol. Cell. Biol. 17:1848-59
30. Edmondson DG, Cheng TC, Cserjesi P, Chakraborty T, Olson EN. 1992. Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF2. Mol. Cell Biol. 12:3665-77
31. Edmondson DG, Lyons GE, Martin JF, Olson EN. 1994. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development 120:1251-63
32. Feo S, Antona V, Barbieri G, Passantino R, Cali L, Giallongo A. 1995. Transcription of the human beta enolase gene (ENO-3) is regulated by an intronic muscle-specific enhancer that binds myocyte-specific enhancer factor 2 proteins and ubiquitous G-rich-box binding factors. Mol. Cell. Biol. 15:5991-6002
33. Ferrari S, Molinari S, Melchionna R, Cusella-De Angelis MG, Battini R, et al. 1997. Absence of MEF2 binding to the A/T-rich element in the muscle creatine kinase (MCK) enhancer correlates with lack of early expression of the MCK gene in embryonic mammalian muscle. Cell Growth Diff. 8:23-34
34. Fickett JW. 1996a. Coordinate positioning of MEF2 and myogenin binding sites. Gene 172:GC19-32
35. Fickett JW. 1996b. Quantitative discrimination of MEF2 sites. Mol. Cell. Biol. 16:437-41
36. Firulli AB, Miano JM, Bi W, Johnson AD, Cass-cells W, et al. 1996. Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells. Association with the activated phenotype. Circ. Res. 78:196-204
37. Gahlmann R, Kedes L. 1993. Tissue-specific restriction of skeletal muscle troponin C gene expression Gene Exp. 3:11-25
38. Gajewski K, Kim Y, Lee YM, Olson EN, Schulz RA. 1997. D-mef2 is a target for Tinman activation during Drosophila heart development. EMBO J. 16:515-22
39. Gitelman I. 1997. Twist protein in mouse embryogenesis. Dev. Biol. 189:205-14
40. Gossett LA, Kelvin DJ, Sternberg EA, Olson EN. 1989. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell. Biol. 9:5022-33
41. Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ. 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296-99
42. Han TH, Prywes R. 1995. Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol. Cell. Biol. 15:2907-15
43. Harvey R. 1996. NK-2 homeobox genes and heart development. Dev. Biol. 178:203-16
44. Hebrok M, Wertz K, Fuchtbauer EM. 1994. M-twist is an inhibitor of muscle differentiation. Dev. Biol. 165:537-44
45. Hidaka K, Morisaki T, Byun SH, Hashido K, Toyama K, Mukai T. 1995. The MEF2B homologue differentially expressed in mouse embryonal carcinoma cells. Biochem. Biophys. Res. Commun. 213:555-60
46. Hidaka K, Yamamoto I, Arai Y, Mukai T. 1993. The MEF-3 motif is required for MEF-2-mediated skeletal muscle-specific induction of the rat aldolase A gene. Mol. Cell. Biol. 13:6469-78
47. Hobson GM, Krahe R, Garcia E, Siciliano MJ, Funanage VL. 1995. Regional chromosomal assignments for four members of the MADS domain transcription enhancer factor 2 (MEF2) gene family to human chromosomes 15q26, 19p12, 5q14, and 1q12-q23. Genomics 29:704-11
48. Ikeshima H, Imai S, Shimoda K, Hata J, Takano T. 1995. Expression of a MADS box gene, MEF2D, in neurons of the mouse central nervous system: implication of its binary function in myogenic and neurogenic cell lineages. Neurosci. Lett. 200:117-20
49. Joh K, Takano K, Mukai T, Hori K. 1991. Analysis of upstream regulatory regions required for the activities of two promoters of the rat aldolase A gene. FEBS Lett. 292:128-32
50. Kato Y, Kravchenko VV, Tapping RI, Han J, Ulevitch RJ, Lee JD. 1997. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16:7054-66
51. Katoh Y, Loukianov E, Kopras E, Zilberman A, Periasamy M. 1994. Identification of functional promoter elements in the rabbit smooth muscle myosin heavy chain gene. J. Biol. Chem. 269:30538-45
52. Kaushal S, Schneider JW, Nadal-Ginard B, Mahdavi V. 1994. Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. Science 266:1236-40
53. Klamut HJ, Bosnoyan-Collins LO, Worton RG. Ray PN. 1997. A muscle-specific enhancer within intron 1 of the human dystrophin gene is functionally dependent on single MEF-1/E box and MEF-2/AT-rich sequence motifs. Nucleic Acids Res. 25:1618-25
54. Kuisk IR, Li H, Tran D, Capetanaki Y. 1996. A single MEF2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis. Dev. Biol. 174:1-13
55. Lassar AB, Davis RL, Wright WE, Kadesch T, Murre C, et al. 1991. Functional activity of myogenic bHLH proteins requires heterooligomerization with E12/E47-like proteins in vivo. Cell 66:305-15
56. Lee KJ, Hickey R, Zhu H, Chien KR. 1994. Positive regulatory elements (HF-1a and HF-1b) and a novel negative regulatory element (HF-3) mediate ventricular muscle-specific expression of myosin light-chain 2-luciferase fusion genes in transgenic mice. Mol. Cell. Biol. 14:1220-29
57. Lee Y, Nadal-Ginard B, Mahdavi V, Izumo S. 1997. Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the alpha-cardiac myosin heavy-chain gene. Mol. Cell. Biol. 17:2745-55
58. Leibham D, Wong MW, Cheng TC, Schroeder S, Weil PA, et al. 1994. Binding of TFIID and MEF2 to the TATA element activates transcription of the Xenopus MyoDa promoter. Mol. Cell. Biol. 14:686-99
59. Leifer D, Golden J, Kowall NW. 1994. Myocyte-specific enhancer binding factor 2C expression in human brain development. Neuroscience 63:1067-79
60. Leifer D, Krainc D, Yu YT, McDermott J, Breitbart RE, et al. 1993. MEF2C, a MADS/ MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc. Natl. Acad. Sci. USA 90:1546-50
61. Li H, Capetanaki Y. 1994. An E box in the desmin promoter cooperates with the E box and MEF-2 sites of a distal enhancer to direct muscle-specific transcription. EMBO J. 13-3580-89
62. Lilly B, Galewsky S, Firulli AB, Schulz RA, Olson EN. 1994. D-MEF2: a MADS box transcription factor expressed in differentiating mesoderm and muscle cell lineages during Drosophila embryogenesis. Proc. Natl. Acad. Sci. USA 91:5662-66
63. Lilly B, Zhao B, Ranganayakulu G, Paterson BM, Schulz RA, Olson EN. 1995. Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science 267:688-93
64. Lin MH, Bour BA, Abmayr SM, Storti RV. 1997. Ectopic expression of MEF2 in the epidermis induces epidermal expression of muscle genes and abnormal muscle development in Drosophila. Dev. Biol. 182:240-55
65. Lin MH, Nguyen HT, Dybala C, Storti RV. 1996. Myocyte-specific enhancer factor 2 acts cooperatively with a muscle activator region to regulate Drosophila tropomyosin gene muscle expression [published erratum appears in Proc. Natl. Acad. Sci. USA, 1996. 23;93(15):8152-3]. Proc. Natl. Acad. Sci. USA 93:4623-28
66. Lin Q, Schwarz J, Bucana C, Olson EN. 1997. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404-7
67. Lin SC, Lin MH, Horvath P, Reddy KL, Storti RV. 1997. PDP1, a novel Drosophila PAR domain bZIP transcription factor expressed in developing mesoderm, endoderm and ectoderm, is a transcriptional regulator of somatic muscle genes. Development 124:4685-96
68. Lin SC, Storti RV. 1997. Developmental regulation of the Drosophila Tropomyosin I (TmI) gene is controlled by a muscle activator enhancer region that contains multiple cis-elements and binding sites for multiple proteins Dev. Gen. 20:297-306
69. Lin X, Shah S, Bulleit RF. 1996. The expression of MEF2 genes is implicated in CNS neuronal differentiation. Brain Res. Mol. Brain Res. 42:307-16
70. Lints TJ, Parsons LM, Hartley L, Lyons I, Harvey RP. 1993. Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development 119:419-31
71. Liu ML, Olson AL, Edgington NP, Moye-Rowley WS, Pessin JE. 1994. Myocyte enhancer factor 2 (MEF2) binding site is essential for C2C12 myotube-specific expression of the rat GLUT4/muscle-adipose facilitative glucose transporter gene. J. Biol. Chem. 269:28514-21
72. Liu S, Liu P, Borras A, Chatila T, Speck SH. 1997. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J. 16:143-53
73. Ludolph DC, Konieczny SF. 1995. Transcription factor families: muscling in on the myogenic program. FASEB J. 9:1595-604
74. Lyons GE, Micales BK, Schwarz J, Martin JF, Olson EN. 1995. Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J. Neurosci. 15:5727-38
75. Malik S, Huang CF, Schmidt J. 1995. The role of the CANNTG promoter element (E box) and the myocyte-enhancer-binding-factor -2 (MEF-2) site in the transcriptional regulation of the chick myogenin gene. Eur. J. Biochem. 230:88-96
76. Mao Z, Nadal-Ginard B. 1996. Functional and physical interactions between mammalian achaete-scute homolog 1 and myocyte enhancer factor 2A. J. Biol. Chem. 271:14371-75
77. Martin JF, Miano JM, Hustad CM, Copeland NG, Jenkins NA, Olson EN. 1994. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol. Cell. Biol. 14:1647-56
78. Martin JF, Schwarz JJ, Olson EN. 1993. Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc. Natl. Acad. Sci. USA 90:5282-86
79. McDermott JC, Cardoso MC, Yu YT, Andres V, Leifer D, et al. 1993. hMEF2C gene encodes skeletal muscle-and brain-specific transcription factors. Mol. Cell. Biol. 13:2564-77
80. McGrew MJ, Bogdanova N, Hasegawa K, Hughes SH, Kitsis RN, Rosenthal N. 1996. Distinct gene expression patterns in skeletal and cardiac muscle are dependent on common regulatory sequences in the MLC1/3 locus. Mol. Cell. Biol. 16:4524-34
81. Meierhans D, Sieber M, Allemann RK. 1997. High affinity binding of MEF-2C correlates with DNA bending. Nucleic Acids Res. 25:4537-44
82. Michelson A, Abmayr SM, Bate M, Martinez-Arias A, Mantiatis T. 1990. Expression of a MyoD family member prefigures muscle pattern in Drosophila embryos. Genes Dev. 4:2086-97
83. Molkentin JD, Black BL, Martin JF, Olson EN. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83:1125-36
84. Molkentin JD, Black BL, Martin JF, Olson EN. 1996a. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol. Cell. Biol. 16:2627-36
85. Molkentin JD, Firulli AB, Black BL, Martin JF, Hustad CM, et al. 1996b. MEF2B is a potent transactivator expressed in early myogenic lineages. Mol. Cell. Biol. 16:3814-24
86. Molkentin JD, Li L, Olson EN. 1996c. Phosphorylation of the MADS-box transcription factor MEF2C enhances its DNA binding activity. J. Biol. Chem. 271:17199-204
87. Molkentin JD, Markham BE. 1993. Myocyte-specific enhancer-binding factor (MEF-2) regulates alpha-cardiac myosin heavy chain gene expression in vitro and in vivo. J. Biol. Chem. 268:19512-20
88. Molkentin JD, Markham BE. 1994. An M-CAT binding factor and an RSRF-related A-rich binding factor positively regulate expression of the alpha-cardiac myosin heavy-chain gene in vivo. Mol. Cell. Biol. 14:5056-65
89. Molkentin JD, Olson EN. 1996. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. USA 93:9366-73
90. Morisaki T, Holmes EW. 1993. Functionally distinct elements are required for expression of the AMPD1 gene in myocytes. Mol. Cell. Biol. 13:5854-60
91. Morisaki T, Sermsuvitayawong K, Byun SH, Matsuda Y, Hidaki K, et al. 1997. Mouse MEF2B gene-unique member of MEF2 gene family. J. Biochem. 122:939-46
92. 2+ adenosine triphosphatase gene is increased by 3,5,3′-triiodothyronine receptor isoform-specific interactions with the myocyte-specific enhancer factor-2a. Endocrinology 138: 26-32
93. Muscat GE, Perry S, Prentice H, Kedes L. 1992. The human skeletal alpha-actin gene is regulated by a muscle-specific enhancer that binds three nuclear factors. Gene Exp. 2:111-26
94. Naidu PS, Ludolph DC, To RQ, Hinterberger TJ, Konieczny SF. 1995. Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis. Mol. Cell. Biol. 15:2707-18
95. Nakatsuji Y, Hidaka K, Tsujino S, Yamamoto Y, Mukai T, et al. 1992. A single MEF-2 site is a major positive regulatory element required for transcription of the muscle-specific subunit of the human phosphoglycerate mutase gene in skeletal and cardiac muscle cells. Mol. Cell. Biol. 12:4384-90
96. Nakayama M, Stauffer J, Cheng J, Banerjee-Basu S, Wawrousek E, Buonanno A. 1996. Common core sequences are found in skeletal muscle slow- and fast-fiber-type-specific regulatory elements. Mol. Cell. Biol. 16:2408-17
97. Navankasattusas S, Zhu H, Garcia AV, Evans SM, Chien KR. 1992. A ubiquitous factor (HF-1a) and a distinct muscle factor (HF-1b/MEF-2) form an E-box-independent pathway for cardiac muscle gene expression. Mol. Cell. Biol. 12:1469-79
98. Nguyen HT, Bodmer R, Abmayr SM, McDermott JC, Spoerel NA. 1994. D-mef2: a Drosophila mesoderm-specific MADS box-containing gene with a biphasic expression profile during embryogenesis. Proc. Natl. Acad. Sci. USA 91:7520-24
99. Nishio H, Takeshima Y, Narita N, Yanagawa H, Suzuki Y, et al. 1994. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter. J. Clin. Invest. 94:1037-42
100. Nurrish SJ, Treisman R. 1995. DNA binding specificity determinants in MADS-box transcription factors. Mol. Cell. Biol. 15:4076-85
101. Olson EN, Perry M, Schulz RA. 1995. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev. Biol. 172:2-14
102. Ornatsky OI, Andreucci JJ, McDermott JC. 1997. A dominant-negative form of transcription factor MEF2 inhibits myogenesis. J. Biol. Chem. 272:33271-78
103. Ornatsky OI, McDermott JC. 1996. MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells. J. Biol. Chem. 271:24927-33
104. Parmacek MS, Ip HS, Jung F, Shen T, Martin JF, et al. 1994. A novel myogenic regulatory circuit controls slow/cardiac troponin C gene transcription in skeletal muscle. Mol. Cell. Biol. 14:1870-85
105. Paterson BM, Walldorf U, Eldridge J, Dubendorfer A, Frasch M, Gehring W. 1991. The Drosophila homolog of vertebrate myogenic-determination genes encodes a transiently expressed nuclear protein marking primary myogenic cells. Proc. Natl. Acad. Sci. USA 88:3782-86
106. Pellegrini L, Tan S, Richmond TJ. 1995. Structure of serum response factor core bound to DNA. Nature 376:490-98
107. Pinney DF, de la Brousse FC, Faerman A, Shani M, Maruyama K, Emerson CP Jr. 1995. Quail myoD is regulated by a complex array of cis-acting control sequences. Dev. Biol. 170:21-38
108. Pollock R, Treisman R. 1991. Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev. 5:2327-41
109. Ranganayakulu G, Zhao B, Dokidis A, Molkentin JD, Olson EN, Schulz RA. 1995. A series of mutations in the D-MEF2 transcription factor reveal multiple functions in larval and adult myogenesis in Drosophila. Dev. Biol. 171:169-81
110. Rao A, Luo C, Hogan PG. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707-47
111. Rao MV, Donoghue MJ, Merlie JP, Sanes JR. 1996. Distinct regulatory elements control muscle-specific, fiber-type-selective, and axially graded expression of a myosin light-chain gene in transgenic mice. Mol. Cell. Biol. 16:3909-22
112. Riechmann JL, Meyerowitz EM. 1997. Determination of floral organ identity by Arabidopsis MADS domain homeotic proteins AP1, AP3, PI, and AG is independent of their DNA-binding specificity. Mol. Biol. Cell 8:1243-59
113. Rohwedel J, Horak V, Hebrok M, Fuchtbauer EM, Wobus AM. 1995. M-twist expression inhibits mouse embryonic stem cell-derived myogenic differentiation in vitro. Exp. Cell Res. 220:92-100
114. Ross RS, Navankasattusas S, Harvey RP, Chien KR. 1996. An HF-1a/HF-1b/MEF-2 combinatorial element confers cardiac ventricular specificity and establishes an anterior-posterior gradient of expression. Development 122:1799-809
115. Rozek D, Pfeifer GP. 1995. In vivo protein-DNA interactions at the c-jun promoter in quiescent and serum-stimulated fibroblasts. J. Cell. Biochem. 57:479-87
116. Salminen M, Spitz F, Fiszman MY, Demignon J, Kahn A, et al. 1995. Myotube-specific activity of the human aldolase A M-promoter requires an overlapping binding site for NF1 and MEF2 factors in addition to a binding site (M1) for unknown proteins. J. Mol. Biol. 253:17-31
117. Sartorelli V, Huang J, Hamamori Y, Kedes L. 1997. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17:1010-26
118. Schulz RA, Chromey C, Lu MF, Zhao B, Olson EN. 1996. Expression of the D-MEF2 transcription factor in the Drosophila brain suggests a role in neuronal cell differentiation. Oncogene 12:1827-31
119. Shore P, Sharrocks AD. 1995. The MADS-box family of transcription factors. Eur. J. Biochem. 229:1-13
120. Skopicki HA, Lyons GE, Schatteman G, Smith RC, Andres V, et al. 1997. Embryonic expression of the Gax homeodomain protein in cardiac, smooth, and skeletal muscle. Circ. Res. 80:452-62
121. Spicer DB, Rhee J, Cheung WL, Lassar AB. 1996. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science 272:1476-80
122. Srivastava D, Thomas T, Lin Q, Kirby ML, Brown D, Olson EN. 1997. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat. Genet. 16:154-60
123. Subramanian SV, Nadal-Ginard B. 1996. Early expression of the different isoforms of the myocyte enhancer factor-2 (MEF2) protein in myogenic as well as non-myogenic cell lineages during mouse embryogenesis. Mech. Dev. 57:103-12
124. Suzuki E, Guo K, Kolman M, Yu YT, Walsh K. 1995. Serum induction of MEF2/RSRF expression in vascular myocytes is mediated at the level of translation. Mol. Cell. Biol. 15:3415-23
125. Suzuki E, Lowry J, Sonoda G, Testa JR, Walsh K. 1996. Structures and chromosome locations of the human MEF2A gene and a pseudogene MEF2AP. Cytogen. Cell Gen. 73:244-49
126. Taylor JM, Dupont-Versteegden EE, Davies JD, Hassell JA, Houle JD, et al. 1997. A role for the ETS domain transcription factor PEA3 in myogenic differentiation. Mol. Cell. Biol. 17:5550-58
127. Taylor MV, Beatty KE, Hunter HK, Baylies MK. 1995. Drosophila MEF2 is regulated by twist and is expressed in both the primordia and differentiated cells of the embryonic somatic, visceral and heart musculature [published erratum appears in Mech. Dev. 1995, 51(1):139-41] Mech. Dev. 50:29-41
128. Theissen G, Kim JT, Saedler H. 1996. Classification and phylogeny of the MADS-box multigene family suggest defined roles of MADS-box gene subfamilies in the morphological evolution of eukaryotes. J. Mol. Evol. 43:484-516
129. Theissen G, Saedler H. 1995. MADS-box genes in plant ontogeny and phylogeny: Haeckel's "biogenetic law" revisited. Curr. Opin. Gen. Dev. 5:628-39
130. Ticho BS, Stainier DY, Fishman MC, Breitbart RE. 1996. Three zebrafish MEF2 genes delineate somitic and cardiac muscle development in wild-type and mutant embryos. Mech. Dev. 59:205-18
131. Wang G, Yeh HI, Lin JJ. 1994. Characterization of cis-regulating elements and trans-activating factors of the rat cardiac troponin T gene. J. Biol. Chem. 269:30595-603
132. Weintraub H, Dwarki VJ, Verma I, Davis R, Hollenberg S, et al. 1991. Muscle-specific transcriptional activation by MyoD. Genes Dev. 5:1377-86
133. West AG, Shore P, Sharrocks AD. 1997. DNA binding by MADS-box transcription factors: a molecular mechanism for differential DNA bending. Mol. Cell. Biol. 17:2876-87
134. Winter B, Braun T, Arnold HH. 1992. Cooperativity of functional domains in the muscle-specific transcription factor Myf-5. EMBO J. 11:1843-55
135. Woronicz JD, Lina A, Calnan BJ, Szychowski S, Cheng L, Winoto A. 1995. Regulation of Nur77 orphan steroid receptor in activation-induced apoptosis. Mol. Cell. Biol. 15:6364-76
136. Wong MW, Pisegna M, Lu MF, Leibham D, Perry M. 1994. Activation of Xenopus MyoD transcription by members of the MEF2 protein family. Dev. Biol. 166:683-95
137. Wright WE, Binder M, Funk W. 1991. Cyclic amplification and selection of targets (CAST-ing) for the myogenin consensus binding site. Mol. Cell. Biol. 11:4104-10
138. Yee SP, Rigby PW. 1993. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev. 7:1277-89
139. Yu YT. 1996. Distinct domains of myocyte enhancer binding factor-2A determining nuclear localization and cell type-specific transcriptional activity. J. Biol. Chem. 271:24675-83
140. Yu YT, Breitbart RE, Smoot LB, Lee Y, Mahdavi V, Nadal-Ginard B. 1992. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev. 6:1783-98
141. Yun K, Wold B. 1996. Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr. Opin. Cell Biol. 8:877-89